Thomas Faunce
#116,224
Most Influential Person Now
Australian academician
Thomas Faunce's AcademicInfluence.com Rankings
Thomas Fauncelaw Degrees
Law
#2630
World Rank
#3271
Historical Rank
Common Law
#190
World Rank
#206
Historical Rank
International Law
#1060
World Rank
#1281
Historical Rank
Thomas Fauncephilosophy Degrees
Philosophy
#10479
World Rank
#14368
Historical Rank
Bioethics
#87
World Rank
#87
Historical Rank
Logic
#8092
World Rank
#10070
Historical Rank
Download Badge
Law Philosophy
Why Is Thomas Faunce Influential?
(Suggest an Edit or Addition)According to Wikipedia, Thomas Faunce was a professor at the Australian National University , Canberra, Australia. He practiced both law and medicine, and his professorship was a joint one, being in both the ANU College of Law and Medical School. His research spanned across health law, bioethics, the regulatory governance of pharmaceutical industry and artificial photosynthesis in addressing environment sustainability issues. He was awarded research funding from the Australian Research Council for several Discovery Projects, and in 2009 was awarded a Future Fellowship to study nanotechnology and global public health.
Thomas Faunce's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Artificial Photosynthesis as a Frontier Technology for Energy Sustainability (2013) (252)
- Energy and Environment Policy Case for a Global Project on Artificial Photosynthesis (2013) (242)
- Nanosilver and Global Public Health: International Regulatory Issues (2010) (121)
- Health Assets in a Global Context: Theory, Methods, Action (2011) (86)
- Practical virtue ethics: healthcare whistleblowing and portable digital technology (2005) (83)
- Global Public Goods (2012) (74)
- Sunscreen Safety: The Precautionary Principle, The Australian Therapeutic Goods Administration and Nanoparticles in Sunscreens (2008) (68)
- Integrated Research into the Nanoparticle-Protein Corona: A New Focus for Safe, Sustainable and Equitable Development of Nanomedicines (2008) (62)
- Decision-analytical modelling in health-care economic evaluations (2008) (62)
- Three Australian whistleblowing sagas: lessons for internal and external regulation (2004) (61)
- Will international human rights subsume medical ethics? Intersections in the UNESCO Universal Bioethics Declaration (2005) (55)
- Supporting whistleblowers in academic medicine: training and respecting the courage of professional conscience (2004) (54)
- Planetary medicine and the Waitangi Tribunal Whanganui River report: global health law embracing ecosystem as patients. (2013) (51)
- Textbook of International Health: Global Health in a Dynamic World (2011) (46)
- 'Linkage' pharmaceutical evergreening in Canada and Australia (2007) (37)
- Environmental Sustainability and Global Health Law (2014) (32)
- Will the Australia–United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme? (2004) (31)
- Nanotherapeutics: new challenges for safety and cost‐effectiveness regulation in Australia (2007) (30)
- Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy (2005) (30)
- On-grid batteries for large-scale energy storage: Challenges and opportunities for policy and technology (2018) (28)
- Reference pricing for pharmaceuticals: is the Australia–United States Free Trade Agreement affecting Australia's Pharmaceutical Benefits Scheme? (2007) (27)
- Challenges to Australia's national health policy from trade and investment agreements (2012) (26)
- Nanotechnology and the International Law of Weaponry: Towards International Regulation of Nano-Weapons (2010) (23)
- Assessing the Safety and Cost-Effectiveness of Early Nanodrugs (2009) (23)
- Toxicological and public good considerations for the regulation of nanomaterial-containing medical products (2008) (22)
- ‘Atypical’ Antidepressants in Overdose (2003) (22)
- Three Proposals for Rewarding Novel Health Technologies Benefiting People Living in Poverty. A Comparative Analysis of Prize Funds, Health Impact Funds and a Cost-Effectiveness/Competitive Tender Treaty (2008) (20)
- Ethical Issues in Governing Biobanks: Global Perspectives (2009) (20)
- The affordability of prescription medicines in Australia: are copayments and safety net thresholds too high? (2013) (19)
- Private health insurance and regional Australia (2005) (18)
- Whistleblowing and scientific misconduct: renewing legal and virtue ethics foundations. (2007) (18)
- Toward a treaty on safety and cost-effectiveness of pharmaceuticals and medical devices: enhancing an endangered global public good (2006) (18)
- Public hospitals in China: privatisation, the demise of universal health care and the rise of patient-doctor violence. (2006) (18)
- Developing and teaching the virtue-ethics foundations of healthcare whistle blowing. (2004) (18)
- Tendering for Low Cost Generics in Australia (2006) (17)
- Normative foundations of technology transfer and transnational benefit principles in the UNESCO Universal Declaration on Bioethics and Human Rights. (2009) (17)
- Impact of the Australia—US Free Trade Agreement on Australian Medicines Regulation and Prices (2010) (17)
- Towards a Global Solar Fuels Project - Artificial Photosynthesis and the Transition from Anthropocene to Sustainocene (2012) (17)
- Exploring the Safety of Nanoparticles in Australian Sunscreens (2010) (16)
- Drug Price Reforms: The New F1–F2 Bifurcation (2007) (16)
- A Critical Analysis of Overseas-Trained Doctor ('OTD') Factors in the Bundaberg Base Hospital Surgical Inquiry (2006) (16)
- The Vioxx Pharmaceutical Scandal: Peterson v. Merke Sharpe & Dohme (Aust) Pty Ltd (2010) 184 Fcr 1 (2010) (16)
- Balancing intellectual monopoly privileges and the need for essential medicines (2007) (16)
- Fiduciary disclosure of medical mistakes: the duty to promptly notify patients of adverse health care events. (2005) (15)
- The case for newborn screening for congenital adrenal hyperplasia in Australia (2010) (15)
- Of Consents And Consorts: Reporting Ethics, Law, And Human Rights In Rcts Involving Monitored Overdose Of Healthy Volunteers Pre And Post The “Consort” Guidelines (2003) (15)
- Developing and teaching the virtue-ethics foundations of healthcare whistle blowing (2004) (13)
- Researching safety and cost-effectiveness in the life cycle of nanomedicine. (2007) (13)
- Three Australian whistleblowing sagas: lessons for internal and external regulation (2004) (13)
- Nanotechnology in Global Medicine and Human Biosecurity: Private Interests, Policy Dilemmas, and the Calibration of Public Health Law (2007) (13)
- Using portable digital technology for clinical care and critical incidents: a new model. (2005) (13)
- Pilgrims in Medicine: Conscience, Legalism and Human Rights (2004) (12)
- Global Intellectual Property Protection for Innovative Pharmaceuticals: Challenges for Bioethics and Health Law (2005) (12)
- Human serum albumin binding to silica nanoparticles--effect of protein fatty acid ligand. (2014) (12)
- When silence threatens safety: lessons from the first Canberra Hospital neurosurgical inquiry. (2004) (11)
- Governing Planetary Nanomedicine: Environmental Sustainability and a UNESCO Universal Declaration on the Bioethics and Human Rights of Natural and Artificial Photosynthesis (Global Solar Fuels and Foods) (2012) (11)
- Future Perspectives on Solar Fuels (2012) (11)
- Toxicological and public good considerations for the regulation of nanomaterial-containing medical products. (2008) (10)
- Melatonin supplementation from early morning auto-urine drinking. (1991) (10)
- Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal (2007) (10)
- Policy challenges of nanomedicine for Australia's PBS. (2009) (10)
- Global Clinical Trials: Effective Implementation and Management (2012) (10)
- Flexner's ethical oversight reprised? Contemporary medical education and the health impacts of corporate globalisation (2005) (9)
- Bilateral trade agreements as drivers of national and transnational benefit from health technology policy: implications of recent US deals for Australian negotiations with China and India (2008) (9)
- Nanotechnology For a Sustainable World: Global ARtificial Photosynthesis as the Moral Culmination of Nanotechnology (2012) (9)
- Global Health & Global Aging (2008) (9)
- The Messiha and Schiavo cases: third‐party ethical and legal interventions in futile care disputes (2005) (9)
- Nanowaste : Need for Disposal and Recycling Standards (2017) (9)
- Trade Related Aspects of Intellectual Property Rights (TRIPS) and the Threat to Patients: A Plea for Doctors to Respond Internationally (1998) (9)
- Food Production and Animal Welfare Legislation in Australia: Failing Both Animals and the Environment (2017) (8)
- Towards Global Artificial Photosynthesis (Global Solar Fuels): Energy, Nanochemistry and Governance (2012) (8)
- A backdoor to higher medicine prices? Intellectual property and the Australia-US Free Trade Agreement (2003) (7)
- Medical disclosure and consent forms: proposal for an international standard. (1997) (7)
- New forms of evergreening in Australia: misleading advertising, enantiomers and data exclusivity: Apotex v Servier and Alphapharm v Lundbeck. (2008) (7)
- Collaborative Research Trials: A Strategy for Fostering Mental Health Protections in Developing Nations (2005) (6)
- Will International Trade Law Promote or Inhibit Global Artificial Photosynthesis? (2011) (6)
- Safety of nanoparticles in sunscreens. (2009) (6)
- Governing Nanotechnology for Solar Fuels: Towards a Jurisprudence of Global Artificial Photosynthesis (2011) (6)
- The Oxford Textbook of Clinical Research Ethics (2008) (6)
- Nanotechnology for a Sustainable World: Global Artificial Photosynthesis As Nanotechnology's Moral Culmination (2012) (6)
- The UNESCO Bioethics Declaration ‘social responsibility ’ principle and cost-effectiveness price evaluations for essential medicines (2005) (6)
- Potential impact of AUSFTA on Australia's blood supply (2006) (6)
- Trans-Tasman Therapeutic Products Authority: Potential AUSFTA Impacts on Safety and Cost-Effectiveness Regulation for Medicines and Medical Devices in New Zealand (2006) (6)
- Australia's First Official Illicit Pill Testing at Canberra's Groovin' the Moo Music Festival: Legal Hurdles and Future Prospects. (2018) (5)
- Bioethics and Human Rights (2014) (5)
- Nanomaterial Governance, Planetary Health, and the Sustainocene Transition (2014) (5)
- Recent legal developments and the authority of the Australian Therapeutic Goods Administration. (2009) (5)
- Book review: The Body Hunters: How the Drug Industry Tests Its Products on the World's Poorest Patients (2006) (5)
- Global intellectual property protection of “innovative” pharmaceuticals (2006) (5)
- Australian pharmaceutical policy and the idea of innovation (2008) (5)
- Global artificial photosynthesis: Challenges for bioethics and the human right to enjoy the benefit of scientific progress (2013) (5)
- Global Justice and Bioethics (2012) (5)
- Normative role for medical humanities (2003) (5)
- Global Artificial Photosynthesis and Renewable Energy Storage and Policy for the Sustainocene (2018) (5)
- Civil liberties and the critics of safe vaccination: Australian Vaccination Network Inc v Health Care Complaints Commission [2012] NSWSC 110. (2012) (5)
- Ch 21. 'Future Perspectives on Solar Fuels' (2012) (5)
- 'Atypical' Antidepressants in Overdose Considerations with Respect to Safety (2003) (4)
- Health and Medical Research (2010) (4)
- Global artificial photosynthesis project: a scientific and legal introduction. (2011) (4)
- Analysis of Australia's New Biosecurity Legislation. (2018) (4)
- Because they have evidence: Globalizing financial incentives for corporate fraud whistleblowers (2014) (4)
- The Proposed Ban on Certain Nanomaterials for Electrical and Electronic Equipment in Europe and Its Global Security Implications: A Search for an Alternative Regulatory Approach (2011) (4)
- AUSTRALIAN COMPETITION AND CONSUMER COMMISSION v ACN 117 372 915: SHOULD CONSUMER LAW REGULATE DOCTOR-PATIENT RELATIONS IN A CORPORATISED HEALTH CARE SYSTEM? (2015) (4)
- Health, Trade and Human Rights (2007) (4)
- Sustainable fuel, food, fertilizer and ecosystems through a global artificial photosynthetic system: overcoming anticompetitive barriers (2015) (4)
- The UNESCO Universal Declaration on Bioethics and Human Rights and the normative transition from Corporatocene to Sustainocene (2018) (4)
- Global artificial photosynthesis: transition from Corporatocene to Sustainocene (2016) (4)
- Nano-Safety or Nano-Security? Reassessing Europe's Nanotechnology Regulation in the Context of International Security Law (2012) (4)
- Recovering fraudulent claims for Australian federal expenditure on pharmaceuticals and medical devices. (2010) (4)
- Withdrawing treatment at the direct or indirect request of patients or in their best interests: HNEAHS v A; Brightwater CG v Rossiter; and Australian Capital Territory v JT. (2009) (4)
- Policy challenges from the "White" Senate inquiry into workplace-related health impacts of toxic dusts and nanoparticles (2006) (4)
- Nanotechnology in Japan: A route to energy security after Fukushima? (2013) (3)
- Who Owns Our Health?: medical professionalism, law and leadership beyond the age of the market state (2007) (3)
- NCDs and the WHO Essential Medicines Lists: children need universal health coverage too. (2019) (3)
- Public Health Impacts of the Proposed Australia-United States Free Trade Agreement: Pharmaceuticals and Food Safety (2004) (3)
- Hearing Australian Aboriginal voices on neglect and sustainability (2009) (3)
- Mercury Pollution from Coal-Fired Power Plants: A Critical Analysis of the Australian Regulatory Response to Public Health Risks. (2018) (3)
- Disclosure of Material Risk as Systems-Error Tragedy: Wallace v Kam (2013) (2013) (3)
- How the Australia-US free trade agreement compromised the pharmaceutical benefits scheme (2015) (3)
- Trials and tribulations in the removal of dextropropoxyphene from the Australian Register of Therapeutic Goods (2013) (3)
- Innovation, Definition of (2012) (3)
- Contemporary and Future Challenges for Australian Nanoregulation (2010) (3)
- Plain Packaging in a Broader Regulatory Framework: Preventing False Claims and Investor State Lobbying (2012) (3)
- University of Western Australia v. Gray: An Academic Duty to Commercialise Research? (2008) (3)
- Australia's embrace of investor state dispute settlement: a challenge to the social contract ideal? (2015) (3)
- Deaths on the table: proposal for an international convention on the investigation and prevention of anaesthetic mortality. (1998) (3)
- Constitutional Limits on Federal Legislation Practically Compelling Medical Employment (2009) (3)
- Potential AUSFTA Trade Disputes Over Off Shore Constructions of Australian Pharmaceutical Policy (2008) (2)
- Nanotechnology Toward the Sustainocene (2014) (2)
- Emerging roles for law and human rights in ethical conflicts surrounding neuro critical care. (2005) (2)
- Australian Senate Committee Report on Transvaginal Mesh Devices. (2018) (2)
- Abandoning the common law: medical negligence, genetic tests and wrongful life in the Australian High Court. (2007) (2)
- Condliff v North Staffordshire Primary Care Trust: Relying on Human Rights to Improve Inequities in Privatised HealthCare - Implications for UK and Australian Health System Reforms (2011) (2)
- Commissions of audit in Australia: health system privatisation directives and civil conscription protections. (2014) (2)
- Social Responsibility Principle (2012) (2)
- Split by Sun: The Tragic History of the Sustainocene (2018) (2)
- The Messiha and Schiavo cases: third-party ethical and legal [corrected] interventions in futile care disputes. (2005) (2)
- Cancer Voices Australia v Myriad Genetics Inc [2013] FCA 65: Should Gene Patent Monopolies Trump Public Health? (2013) (2)
- Artificial Photosynthesis: Feeding and Fuelling the Future (2011) (2)
- The Messiha and Schiavo Cases: Third-Party Ethical and Legal Interventions in Futile Care Disputes (2005) (2)
- Nanotechnology and Military Attacks on Photosynthesis (2014) (2)
- Toward the Sustainocene with global artificial synthesis (2014) (2)
- Non Violation Nullification of Benefit Claims: Opportunities and Dilemmas for Australia in the WTO Dispute Settlement System (2009) (2)
- Crimes amendment (Zoe's law) Bill 2013 (No 2): paradoxical commercial impacts of the conservative agenda on fetal rights. (2014) (2)
- Chapter 18:Future Perspectives on Solar Fuels (2011) (2)
- Public Health and Medicine Policies (2010) (2)
- The Carhart case and late-term abortions -- what's next in Australia? (2007) (2)
- Does the world need a global project on artificial photosynthesis? (2015) (2)
- Selim v Lele and the civil (industrial) conscription prohibition: constitutional protection against federal legislation controlling or privatising Australian public hospitals. (2008) (2)
- Implementing US‐style anti‐fraud laws in the Australian pharmaceutical and health care industries (2011) (2)
- The High Court's lost chance in medical negligence: Tabet v Gett (2010) 240 CLR 537. (2010) (2)
- Regulating RNA Research and CRISPR Gene Drives to Combat Biosecurity Threats. (2018) (2)
- Biosecurity, Investor-State Dispute Settlement and Corporatogenic Climate Change: A Challenge for Australian Public Health Regulation and Human Rights (2019) (1)
- The UK House of Commons report on the influence of the pharmaceutical industry: Lessons for equitable access to medicines in Australia (2005) (1)
- Freedom of information applications as an "evergreening" tactic: Secretary, Department of Health and Ageing v iNOVA Pharmaceuticals (Australia) Pty Ltd (2010) 191 FCR 573; [2010] FCA 1442. (2011) (1)
- Biotechnology and Nanotechnology Regulation in Australia (2014) (1)
- NuCoal Resources Ltd v New South Wales: The mining industry and potential health impacts of investor-state dispute settlement in Australia. (2016) (1)
- Energy and environment policy case for a global project (2013) (1)
- Legal Strategies to Cure the Plastic Planet: Corporate Marriage and Public Health Regulation of Single-Use Non-Biodegradeable Plastics (2018) (1)
- Forensic Nanotechnology, Biosecurity and Medical Professionalism: Improving the Australian Health Care System's Response to Terrorist Bombings (2008) (1)
- Consent forms--forms without substance? A case for model disclosure and consent forms. (1996) (1)
- Condliff V North Staffordshire Primary Care Trust: Can Human Rights Redress Inequities in United Kingdom and Australian Cost-Containment-Driven Health Care Reforms? (2011) (1)
- Powering the world with artificial photosynthesis (2013) (1)
- Re Edwards: Who Owns a Dead Man’s Sperm? (2012) (1)
- Health Legislation: Interpretation Coherent with Conscience and International Human Rights (2005) (1)
- Nanotechnology, plasma, hydrogen from artificial photosynthesis and fuel cells: powering the developing world to the Sustainocene (2014) (1)
- A Comparative Perspective on Australian End-of-Life Law (2012) (1)
- Medical professionals convicted of accessing child pornography--presumptive lifetime prohibition on paediatric practice? Health Care Complaints Commission v Wingate. (2008) (1)
- Safety of nanoparticles in sunscreens (2009) (1)
- Governing the Global Food System Towards the Sustainocene with Artificial Photosynthesis (2016) (1)
- Doctors' Fiduciary Duties to Follow Up and to Promptly Disclose Adverse Events (2007) (1)
- Potential impact of AUSFTA on Australiaˈs blood supply (2007) (1)
- Environmental Sustainability and Global Health Law: The Case Study of Globalizing Artificial Photosynthesis (2014) (1)
- Trade Law and Globalization (2012) (1)
- Bioethics Declaration Universal ethics? Intersections in the UNESCO Will international human rights subsume medical (2005) (1)
- Potential Impact of the TPPA on Public Health and Medicine Policies (2010) (1)
- MYRIAD VOICES AGAINST GENE PATENTS IN THE HIGH COURT. (2015) (1)
- Submission to the Review of Australia’s Plasma FractionationArrangements (2006) (1)
- Will International Trade Law inhibit or promote global artificial photosynthesis (2011) (1)
- The Essendon Football Club Supplements Saga: Exploring Natural Justice for Team Sanctions within Anti-Doping Regulations. (2017) (1)
- Bioethics and Human Rights 29 (2014) (1)
- Normative Role for Medical Humanities (Correspondence) (2003) (0)
- New Australian federal organ and tissue donation legislation: enhanced transplant services but no "opt-out". (2009) (0)
- Potential AUSFTA Dispute Resolution over Off-Shore Constructions of Australian Pharmaceutical Policy (2008) (0)
- Nanoscience for a Sustainable World: A Goal or Set of Principles? (2012) (0)
- Nanotechnology’s Moral Culmination: A Global Artificial Photosynthesis Project (2012) (0)
- Nurturing personal and professional conscience in an age of corporate globalisation: Bill Viola's The Passions (2005) (0)
- Trans Pacific Partnership Agreement - Public Health and Medicines Policies (2010) (0)
- The AUSFTA and 'Fast Track' Regulatory Approval of Medicines: Problems and Opportunities for Australian Academic Innovations in Nanotherapeutics (2007) (0)
- Normative Coherence, Theory of (2012) (0)
- Australian experience towards establishing a pharmacoeconomics regulatory system: a critical analysis (2009) (0)
- Chinese Whispers: Judicial Narratives and the Regulation of Clinical Medicine (1997) (0)
- Brown snake envenomation complicating near drowning and amphetamine overdose. (1999) (0)
- Emerging Technologies: Challenges for Health Care and Environmental Ethics and Rights in an Era of Globalisation (2011) (0)
- Public Health Legislation Prohibiting Sports-Embedded Gambling Advertisting (2017) (0)
- A bad trip for health-related human rights: implications of Momcilovic v The Queen (2011) 85 ALJR 957. (2012) (0)
- Government control over health-related not-for-profit organisations: Agency for International Development v. Alliance for Open Society International Inc 570 US_(2013). (2013) (0)
- Shifting Sovereignty Over Public Health? Corporate interests, the AUSFTA and Australian medicines policy (2005) (0)
- Policy Challenges of Nanomedicine for Australia's Pharmaceutical Benefits Scheme (PBS) (2009) (0)
- Australian professional practice bodies and the tort of negligent investigation. (2009) (0)
- Corporatisation of Community Pharmacy and the Constitutional Prohibition of Civil Conscription for Medical Service Providers (2018) (0)
- High Court of Australia and HIV/AIDS Disease Criminalisation: Aubrey v The Queen and Zaburoni v The Queen. (2017) (0)
- Justins v The Queen: assisted suicide, juries and the discretion to prosecute. (2011) (0)
- Citizens' Juries, Liquid Democracy and Legislative Reform of Australian Compulsory Insurance Schemes for Injury Compensation after Motor Vehicle Accidents. (2019) (0)
- Equitable Access to Nanomedicines (2012) (0)
- International trade agreements and the practice of medicine (2006) (0)
- Senate inquiry into price regulation on the prostheses list. (2018) (0)
- The Proposed Ban on Certain Nanomaterials for Electrical and Electronic Equipment in Europe: Global Security Implications (2012) (0)
- Seeding Australian Regulation of Genomics in the Cloud – Elizabeth Abbott and Thomas Faunce. (2016) (0)
- Peri-Gravid Genetic Screening: The Spectre of Eugenics and Medical Conscientious Non-compliance* (1998) (0)
- Core Normative Components of a Global NES Project (2012) (0)
- Medicines Research and Reference Reimbursement Proposals for a China- Australia Free Trade Agreement (2005) (0)
- Developing an Equivalent to the National Medicines Policy for Medical Devices (2009) (0)
- Cutting for Stone (2009) (0)
- Coherence and healthcare whistle-blowing: A response to Parker (2005) (0)
- Religion, ethics, law and human rights in obstetric research Religion plays an important role in the lives of many medical researchers. In many (2008) (0)
- Governing Planetary Nanomedicine: Environmental Sustainability and a UNESCO Universal Declaration on the Bioethics and Human Rights of Natural and Artificial Photosynthesis (Global Solar Fuels and Foods) (2012) (0)
- Republication: In That Case (2009) (0)
- The case for a new teaching hospital (2006) (0)
- The Australian and New Zealand Intensive Care and Anaesthesia Primary Exam (2005) (0)
- Carney v Newton: expert evidence about the standard of clinical notes. (2007) (0)
- International Conference: Towards Global Artificial Photosynthesis: Energy, Nanochemistry and Governance (GAP I) (2011) (0)
- International Conference: Towards Global Artificial Photosynthesis: Energy, Nanochemistry and Governance (GAP I) (2011) (0)
- Nanomaterial Governance, Planetary Health, Global Artificial Photosynthesis, and the Corporatocene to Sustainocene Transition (2018) (0)
- Nanotechnology-Based Artificial Photosynthesis: Food Security and Animal Rights in the Sustainocene (2014) (0)
- In That Case (2008) (0)
- The Health Legislation Amendment Act 2013 (QLD) and Queensland's health assets privatisation dispute. (2014) (0)
- Medical Breakthrough Signs of life: brain-damaged woman stuns doctors with her tennis skills (2015) (0)
- Nanotechnology for Sustainable Food, Water and Housing (2012) (0)
- Innovation and Insufficient Evidence: The Case for a WTO Agreement on Health Technology Safety and Cost-Effectiveness Evaluation (2010) (0)
- and sustainability Hearing Australian Aboriginal voices on neglect (2009) (0)
- What Makes a Real Man? Gender Norms and Western Australian v. AH [2010] WASCA 172 (2011) (0)
- REGULATION OF AUSTRALIAN MEDICAL PROFESSIONALS AND NATIONAL SECURITY: LESSONS FROM THREE CASE STUDIES. (2016) (0)
- Is capitalism good for our health (2011) (0)
- Danger in new trade agreement with the US (2010) (0)
- Re Edwards (2011) 4 ASTLR: Who Owns a Dead Man's Sperm? (2012) (0)
- Radiological investigation of urinary tract infection in children. (1992) (0)
- Light, Water, Energy and Consciousness: The Past and the Future of Life on Earth (2011) (0)
- Re Herrington: aboriginality and the quality of human rights jurisprudence in end-of-life decisions by the Australian judiciary. (2009) (0)
- Nanotechnology, Climate Change and Renewable Energy (2012) (0)
- Australian Medical Professionals, National Security and Administrative Offshore Punishment of Asylum-Seekers: Regulatory Update Including the Medevac Legislation. (2019) (0)
- Health and Human Rights Edited by Rebecca J Cook and Charles G Ngwena (2008) (0)
- Responding to fraud in the Australian health, pharmaceuticals and medical devices sectors: a proposal for reform (2012) (0)
- Drugs for the developing world. (2006) (0)
- Reducing injustice from recent legislation subsidising insurance and restricting civil liability?: Baker-Morrison v NSW [2009] Aust Torts Reports 81-999; Amaca Pty Ltd v Novek [2009] Aust Torts Reports 82-001. (2010) (0)
- Exploring international legal governance of global solar fuels (2012) (0)
- A methodological framework of preparing economic evidence for selection of medicines in the Chinese setting (2010) (0)
- Withdrawing Treatment at the Direct or Indirect Request of Patients or in Their Best Interests: HNEAHS v. A; Brightwater CG v. Rossiter; and ACT v. JT (2009) (0)
- Should only pharmacists hold pecuniary interests in a pharmaceutical business? Attorney General (NSW) v Now.com.au Pty Ltd [2008] NSWSC 276. (2010) (0)
- Incentives for Global Public Health: Innovation and insufficient evidence: the case for a WTO–WHO Agreement on Health Technology Safety and Cost-Effectiveness Evaluation (2010) (0)
- Global Artificial Photosynthesis: A Scientific and Legal Introduction. (2011) (0)
- Methods for Socio-Economic Evaluation of Marketed MedicinesIII: Factors Affecting Methodological Quality and Transferability (2006) (0)
- Medical loyalty : foundational virtues, principles and human rights in 21st century doctor-patient regulation (2000) (0)
- Stemming the great divide (2015) (0)
- Re Edwards (2011) 4 ASTLR 392: who owns a dead man's sperm? (2012) (0)
- Blowing the Public Whistle (2008) (0)
- Trade and Climate Change (2021) (0)
- Review of 'Ethical Issues in Governing Biobanks: Global Perspectives' (2009) (0)
- Obstacles to Nanotechnology for Environmental Sustainability (2012) (0)
- Nucoal Resources Ltd v NSW: the Mining Industry and Potential Health Impacts of Investor State Dispute Settlement in Australia (2016) (0)
- Pharmaceutical cost-effectiveness pricing: developing and protecting a global ideal form (2006) (0)
- From Conscience and International Trade Law to Global Artificial Photosynthesis in the Sustainocene (2014) (0)
- Nanotechnology for Global Peace and Security (2012) (0)
- AUSTRALIAN COMPETITION AND CONSUMER COMMISSION v PFIZER: EVERGREENING AND MARKET POWER AS A BLOCKBUSTER DRUG GOES OFF PATENT. (2015) (0)
- ACT Human Rights Act: Legality of abortion remains with the Legislative Assembly (2003) (0)
- Literature and Ethics (2009) (0)
- High hopes for nanotechnology benefits, but need for proper safeguards (2006) (0)
- Supervising junior doctors and "on-call" responsibilities: Brus v Australian Capital Territory; Greater Southern Area Health Service v Angus. (2008) (0)
- Medical Law Reporter: Analysis of Australia's New Biosecurity Legislation (2018) (0)
- Government Controls Over Health-Related Not-For-Profit Organisations: Agency for International Development v Alliance for Open Society International (2013) (0)
This paper list is powered by the following services:
Other Resources About Thomas Faunce
What Schools Are Affiliated With Thomas Faunce?
Thomas Faunce is affiliated with the following schools:
